Cleared Traditional

K061123 - PALM ECG RECORDER, MODEL EP-201/202

K061123 is an FDA 510(k) clearance for PALM ECG RECORDER, manufactured by Parama-Tech Company., Ltd.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 431-day FDA review.

K061123 · Parama-Tech Company., Ltd. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2007
Decision
431d
Days
Class 2
Risk

K061123 is an FDA 510(k) clearance for the PALM ECG RECORDER, MODEL EP-201/202. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Parama-Tech Company., Ltd. (Stamford, US). The FDA issued a Cleared decision on June 29, 2007 after a review of 431 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

FDA 510(k) Submission Details - K061123

510(k) Number K061123 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 24, 2006
Decision Date June 29, 2007
Days to Decision 431 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
306d slower than avg
Panel avg: 125d · This submission: 431d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 535
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K061123.
ECG-1250A SERIES CARDIOFAX S AND ECG-1350A SERIES CARDIOFAX M
K072217 · Nihon Kohden America, Inc. · Aug 2007
PORTABLE ECSCOPE
K072353 · Dyansys Corp · Aug 2007
QP-156E ECG EXERCISE TEST OPTION FOR THE ECG-1500A SERIES/CARDIOFAX V
K072060 · Nihon Kohden America, Inc. · Aug 2007
CORSCREEN
K070614 · Viasys Healthcare GmbH · May 2007
AUDICOR 200 SYSTEM, MODELS 200D AND 200S
K070136 · Inovise Medical, Inc. · Apr 2007
MONEBO AUTOMATED ECG ANALYSIS AND INTERPRETATION SOFTWARE LIBRARY, VERSION 3.0
K062282 · Monebo Technologies, Inc. · Mar 2007
K061123 · PALM ECG RECORDER, MODEL EP-201/202
Download PDF FDA Summary Parama-Tech Company.,…